Health
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability – Medical Xpress
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof of principle for a treatment strategy known…
-
Noosa News23 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News23 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
General16 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General16 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting